33P Antitumor activity of TROP2 antibody drug conjugate datopotamab deruxtecan in chemotherapy-resistant breast cancer models
Titel:
33P Antitumor activity of TROP2 antibody drug conjugate datopotamab deruxtecan in chemotherapy-resistant breast cancer models
Auteur:
Meric-Bernstam, F. Yuca, E. Evans, K. Zhao, M. Raso, M.G. Maejima, T. Zheng, X. Rizvi, Y. Akcakanat, A. Scott, S. Wang, B. Byers, L.A. Tripathy, D. Okajima, D. Damodaran, S.